FDA Approves Eohilia for Eosinophilic Esophagitis

FRIDAY, Feb. 16, 2024-- The U.S. Food and Drug Administration has approved Eohilia (budesonide oral suspension) as the first and only oral treatment for eosinophilic esophagitis (EoE).The oral corticosteroid therapy is approved for individuals...